19:58:49 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:HBP - HELIX BIOPHARMA CORP. - https://www.helixbiopharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HBP - T  0.50.99·1.050.11.01+0.011.030.430191.00  1.01  1.001.35  0.5015:54:56Jun 1615 min RT 2¢
TSX - T0.50.99·1.050.11.01+0.011.029.930131.00  1.01  1.001.35  0.5015:54:5615 min
Chi-X - X 1.000.4011.00  1.00  1.0011:21:5015 min
CXD - D 1.000.14    Nov 1215 min
TriAct - M 1.000.0011    Sep 01/2015 min

Recent Trades - Last 10 of 19
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:56:07M1.010.01180 National Bank80 National BankE
15:54:56T1.010.011,00084 ITG8414 Virtu ITGK
15:43:45T1.010.012,00014 Virtu ITG14 Virtu ITGK
15:43:07D1.00 2280 National Bank80 National BankE
15:43:07T1.00 6083 Research Cap7 TD Sec
15:43:07T1.00 90014 Virtu ITG14 Virtu ITGK
15:38:42T1.00 20014 Virtu ITG7 TD SecK
15:38:42T1.00 9,80014 Virtu ITG14 Virtu ITGK
13:06:40T1.00 5,00014 Virtu ITG14 Virtu ITGK
13:05:39T1.00 1,00014 Virtu ITG14 Virtu ITGK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-16 19:00C:HBP0.91News ReleaseHelix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Nine Month Period Ended April 30, 2025
2025-06-16 16:36C:HBP0.91SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-06-16 16:36C:HBP0.91SEDAR Interim MD & ASEDAR Interim MD & A
2025-06-02 20:45C:HBP0.92News ReleaseHelix BioPharma appoints Babbar as CFO
2025-05-20 18:31C:HBP0.95News ReleaseHelix BioPharma closes acquisitions of Laevoroc assets
2025-05-14 19:43C:HBP0.96News ReleaseHelix BioPharma signs capital raising agreement
2025-04-24 17:58C:HBP0.78News ReleaseHelix Bio appoints Kandziora, Kourniaktis as execs
2025-04-10 17:57C:HBP0.79News ReleaseHelix BioPharma promotes Mehrling to CEO
2025-04-03 17:30C:HBP0.79News ReleaseHelix BioPharma hires ITG for market-making services
2025-03-26 18:19C:HBP0.80News ReleaseHelix BioPharma holders approve all matters at AGSM
2025-03-18 08:40C:HBP0.90News ReleaseHelix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three and Six Month Periods Ended January 31, 2025
2025-03-14 19:34C:HBP0.90SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-03-14 19:34C:HBP0.90SEDAR Interim MD & ASEDAR Interim MD & A
2025-03-11 17:50C:HBP0.88News ReleaseHelix's L-DOS47 presentation to be held March 12
2025-03-06 17:48C:HBP0.91News ReleaseHelix BioPharma adds Guggi as CTO, Mehrling as CMO
2025-03-03 20:36C:HBP0.91News ReleaseHelix BioPharma extends AGSM date to March 26
2025-02-24 08:51C:HBP0.98News ReleaseHelix BioPharma Corp. Extends Date of Annual General and Special Meeting to Seek Approval of Asset Acquisitions and Proposed Financing
2025-02-21 20:07C:HBP0.98News ReleaseHelix BioPharma pushes AGSM date to March 26
2025-01-09 19:36C:HBP0.93News ReleaseHelix BioPharma closes $3-million private placement
2024-12-16 17:18C:HBP0.95SEDAR Interim MD & ASEDAR Interim MD & A